Which statement about labeling and coding for investigational products is accurate?

• A. Labeling must meet regulatory standards to ensure traceability.
• B. Labeling is optional for investigational products.
• C. Packaging alone is sufficient without labeling.
• D. Coding is irrelevant to compliance.

Answer: (A)

Labeling and coding are essential for safeguarding traceability and proper handling of investigational products. The label carries the information needed to identify the product unambiguously and to know how it should be stored, used, and tracked throughout the trial. Regulatory standards specify what must appear on the label—such as product identity, trial/investigator details, storage conditions, expiration date, and batch or lot numbers—to ensure that the right product is given to the right participant and that any issues can be traced quickly.

Coding complements labeling by providing unique identifiers for each product, container, or dose unit. This supports inventory control, prevents mix-ups, and enables accurate tracking for adverse event reporting, recalls, and audits. It also helps with blinding and data integrity in certain trial designs.

In short, labeling must meet regulatory standards to ensure traceability and safety, and packaging alone cannot substitute for the critical information contained on the label. Coding is a key part of regulatory compliance because it underpins accurate tracking and accountability throughout the product’s lifecycle in the study.